CADI-R302

CADI-R302 is a discovery-stage research and drug discovery program developed by Bio-Modeling Systems (BMSystems) focusing on disorders of the Central Nervous System (CNS) and Peripheral Nervous System (PNS). The program is built upon the company's proprietary Computer-Assisted Deductive Integration (CADI) platform, which utilizes a non-mathematical heuristic systems biology approach to model complex biological pathways and identify novel therapeutic targets. CADI-R302 specifically maps the biological networks involved in neurodegeneration and neuroinflammation to discover critical intervention points, which may lead to the development of new small molecules, repositioned drug candidates, or multi-target therapeutic protocols. This program serves as the foundational research model for more specific therapeutic programs within the BMSystems pipeline, such as CADI-T3021 for Parkinson's disease.